chr2-50506555-G-A

Variant summary

Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PP3_Moderate

The NM_001330078.2(NRXN1):​c.2437C>T​(p.Arg813Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000146 in 1,613,092 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00015 ( 0 hom. )

Consequence

NRXN1
NM_001330078.2 missense

Scores

14
4
1

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:6B:1

Conservation

PhyloP100: 8.05
Variant links:
Genes affected
NRXN1 (HGNC:8008): (neurexin 1) This gene encodes a single-pass type I membrane protein that belongs to the neurexin family. Neurexins are cell-surface receptors that bind neuroligins to form Ca(2+)-dependent neurexin/neuroligin complexes at synapses in the central nervous system. This complex is required for efficient neurotransmission and is involved in the formation of synaptic contacts. Three members of this gene family have been studied in detail and are estimated to generate over 3,000 variants through the use of two alternative promoters (alpha and beta) and extensive alternative splicing in each family member. Recently, a third promoter (gamma) was identified for this gene in the 3' region. Mutations in this gene are associated with Pitt-Hopkins-like syndrome-2 and may contribute to susceptibility to schizophrenia. [provided by RefSeq, Aug 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 2 ACMG points.

PP3
MetaRNN computational evidence supports a deleterious effect, 0.891

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
NRXN1NM_001330078.2 linkuse as main transcriptc.2437C>T p.Arg813Cys missense_variant 13/23 ENST00000401669.7 NP_001317007.1 E7ERL8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
NRXN1ENST00000401669.7 linkuse as main transcriptc.2437C>T p.Arg813Cys missense_variant 13/235 NM_001330078.2 ENSP00000385017.2 E7ERL8

Frequencies

GnomAD3 genomes
AF:
0.0000657
AC:
10
AN:
152094
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000118
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000805
AC:
20
AN:
248396
Hom.:
0
AF XY:
0.0000742
AC XY:
10
AN XY:
134746
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000169
Gnomad OTH exome
AF:
0.000166
GnomAD4 exome
AF:
0.000154
AC:
225
AN:
1460998
Hom.:
0
Cov.:
31
AF XY:
0.000140
AC XY:
102
AN XY:
726766
show subpopulations
Gnomad4 AFR exome
AF:
0.000120
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000116
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000194
Gnomad4 OTH exome
AF:
0.0000663
GnomAD4 genome
AF:
0.0000657
AC:
10
AN:
152094
Hom.:
0
Cov.:
32
AF XY:
0.0000673
AC XY:
5
AN XY:
74286
show subpopulations
Gnomad4 AFR
AF:
0.0000483
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000118
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000131
Hom.:
0
Bravo
AF:
0.0000756
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.000259
AC:
1
ExAC
AF:
0.0000910
AC:
11
EpiCase
AF:
0.000109
EpiControl
AF:
0.000297

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:6Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Pitt-Hopkins-like syndrome 2 Uncertain:3
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpOct 31, 2022This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 853 of the NRXN1 protein (p.Arg853Cys). This variant is present in population databases (rs201150987, gnomAD 0.02%). This missense change has been observed in individual(s) with neurodevelopmental disorders (PMID: 21424692, 33004838). This variant is also known as R813C. ClinVar contains an entry for this variant (Variation ID: 539874). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. Experimental studies have shown that this missense change does not substantially affect NRXN1 function (PMID: 21424692). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Uncertain significance, criteria provided, single submitterclinical testingRevvity Omics, RevvityDec 21, 2021- -
Uncertain significance, criteria provided, single submitterclinical testingNew York Genome CenterJun 01, 2020- -
not provided Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitterclinical testingMayo Clinic Laboratories, Mayo ClinicJan 26, 2024PP3 -
Likely benign, criteria provided, single submitterclinical testingGeneDxMay 04, 2021This variant is associated with the following publications: (PMID: 21424692) -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsNov 04, 2020The c.2557C>T (p.R853C) alteration is located in exon 14 (coding exon 13) of the NRXN1 gene. This alteration results from a C to T substitution at nucleotide position 2557, causing the arginine (R) at amino acid position 853 to be replaced by a cysteine (C). Based on data from the Genome Aggregation Database (gnomAD) database, the NRXN1 c.2557C>T alteration was observed in 0.01% (22/279786) of total alleles studied, with a frequency of 0.02% (21/127956) in the European (non-Finnish) subpopulation. This alteration has been reported heterozygous as c.2437C>T (p.R813C) once from a cohort of patients with nonsyndromic intellectual disability. Inheritance was not determined. This alteration was also reported heterozygous in a patient with global developmental delay, hypotonia, toe syndactyly, micrognathia, and dysmorphic features as well as in the patient's father who had delay, hearing abnormalities, and learning difficulties. However, the proband also had a 1.18 Mb duplication of unknown significance (Deciphering Developmental Disorders Study, 2015; Gauthier, 2011). This amino acid position is highly conserved in available vertebrate species. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
NRXN1-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesMay 12, 2023The NRXN1 c.2557C>T variant is predicted to result in the amino acid substitution p.Arg853Cys. Using an alternate transcript (NM_004801), this variant is also referred to in the literature as c.2437C>T (p.Arg813Cys aka R813C). This variant was reported in an individual with nonsyndromic intellectual disability (Supplementary Table 1, Gauthier et al. 2011. PubMed ID: 21424692). This variant was also identified in a large-scaler study analyzing risk genes for neurodevelopmental disorders, however limited data was provided (Supplementary Dataset 5, Wang et al. 2020. PubMed ID: 33004838). This variant was also identified in a Deciphering Developmental Disorders Study analyzing individuals with severe, undiagnosed, developmental disorders, however the variant was paternally inherited and the patient also carried a maternally inherited GLI2 variant (Supplementary Table 4, Deciphering Developmental Disorders Study. 2014. PubMed ID: 25533962). Of note, a functional study showed that this variant had similar function to that of controls (Gauthier et al. 2011. PubMed ID: 21424692). This variant is reported in 0.016% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/2-50733693-G-A). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.55
BayesDel_addAF
Pathogenic
0.21
D
BayesDel_noAF
Pathogenic
0.32
CADD
Pathogenic
34
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.74
.;D;.;.;T;.;.;D
Eigen
Pathogenic
0.91
Eigen_PC
Pathogenic
0.88
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Pathogenic
1.0
D;D;D;D;D;D;D;D
M_CAP
Uncertain
0.20
D
MetaRNN
Pathogenic
0.89
D;D;D;D;D;D;D;D
MetaSVM
Uncertain
0.44
D
MutationAssessor
Pathogenic
3.0
.;M;.;.;.;.;.;.
PrimateAI
Pathogenic
0.89
D
PROVEAN
Pathogenic
-6.2
.;D;D;D;.;.;.;.
REVEL
Pathogenic
0.87
Sift
Pathogenic
0.0
.;D;D;D;.;.;.;.
Sift4G
Pathogenic
0.0
D;D;D;D;D;D;D;D
Polyphen
1.0
.;.;D;.;.;.;.;.
Vest4
0.89
MVP
0.38
MPC
1.0
ClinPred
0.79
D
GERP RS
5.7
Varity_R
0.72
gMVP
0.77

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs201150987; hg19: chr2-50733693; COSMIC: COSV58465691; COSMIC: COSV58465691; API